VACV has 170 mass spectrometry (MS)–validated H-2b pMHCI for which immunogenicity has been rigorously tested (15, 30) and mouse models of infection are strictly acute with presentation of epitopes on infected DC directly priming CD8+ T cells (32–38). This evidence concerns the gene CD8A and infection.